This topic contains a solution. Click here to go to the answer

Author Question: Insensitive caregiving relates to all these parental factors EXCEPT a. the parent's own ... (Read 124 times)

2125004343

  • Hero Member
  • *****
  • Posts: 566
Insensitive caregiving relates to all these parental factors EXCEPT
 
  a. the parent's own experience of neglect.
  b. unplanned pregnancies.
  c. a stormy marriage.
  d. genetic predisposition.

Question 2

The 24th week is often set as the legal upper limit for medical abortion. At this point in time, the milestone that is reached by the developing fetus is
 
  a. the heart and circulatory system begin to function.
  b. spontaneous movement is apparent for the first time.
  c. sex differentiation and sex organ development is now completed.
  d. the minimal age of viability has been reached.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

morganmarie791

  • Sr. Member
  • ****
  • Posts: 336
Answer to Question 1

D

Answer to Question 2

D




2125004343

  • Member
  • Posts: 566
Reply 2 on: Jun 22, 2018
Gracias!


mochi09

  • Member
  • Posts: 335
Reply 3 on: Yesterday
Great answer, keep it coming :)

 

Did you know?

Coca-Cola originally used coca leaves and caffeine from the African kola nut. It was advertised as a therapeutic agent and "pickerupper." Eventually, its formulation was changed, and the coca leaves were removed because of the effects of regulation on cocaine-related products.

Did you know?

Cytomegalovirus affects nearly the same amount of newborns every year as Down syndrome.

Did you know?

More than 34,000 trademarked medication names and more than 10,000 generic medication names are in use in the United States.

Did you know?

Atropine was named after the Greek goddess Atropos, the oldest and ugliest of the three sisters known as the Fates, who controlled the destiny of men.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library